SCHEMBL18434826

SCHEMBL18434826

COCCNc1cc2c(c3ncccc13)NSc1ccccc1-2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 7/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ UTS2R Q9UKP6 2/20 0.42
▸ NCF1 P14598 2/20 0.42
▸ CDC7 O00311 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ PRKACA P17612 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CDK7 P50613 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ HIPK2 Q9H2X6 1/20 0.39
▸ IRAK4 Q9NWZ3 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.37
▸ LDHA P00338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18434500 0.85 SLC40A1 (0.63) SLC40A1KDM4EALDH1A1NCF1
SCHEMBL18434469 0.79 SLC40A1 (0.64) SLC40A1CDC7ROCK2PIM1PRKACA
SCHEMBL18434655 0.79 SLC40A1 (0.66) SLC40A1SMN1; SMN2KDM4EALDH1A1CDC7
SCHEMBL18434714 0.78 SLC40A1 (0.66) SLC40A1KDM4EALDH1A1HSD17B10
SCHEMBL11973080 0.77 SLC40A1 (1.00) SLC40A1
SCHEMBL18434824 0.74 SLC40A1 (0.63) SLC40A1SMN1; SMN2KDM4EALDH1A1
SCHEMBL12475058 0.74 SLC40A1 (0.55) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434664 0.74 SLC40A1 (0.55) SLC40A1KDM4EALDH1A1
SCHEMBL18434472 0.74 KDM4E (0.39) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434412 0.74 SLC40A1 (0.55) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675526-B1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2017-02-01 — — EP disclosed
Send feedback